Wednesday, 4 November 2026LatestVideosAboutContact
Latest
US Democratic win unlikely to ease firms' cost, tariff woes in near term, executives say'Doing bad in a game didn't affect me much' - Anshul Kamboj on difficult start to international cricket after match-winning spellBhaichung, Ashalata on AIFF’s SOM list ahead of elections; no men’s footballer from Bengal includedCentre earmarks ₹2,814 crore to boost lithium, nickel processingMatches of Tenerife and Andorra are postponed after tragic passing of Jesus de MiguelRanji Trophy 2026-27: Nagwaswalla, Chintan put Gujarat firmly in commandBeyond heavy trucks: How Tata eyes growth through Iveco’s enginesHC Stays Order Allowing Reopening of Shopian SeminaryNew entrants eat into SIP inflows of listed Mutual fundsCentury Plyboards Q2 net up 46% as all categories record strong volume growthData centers lost the midtermsZee Entertainment adds Golf Tour of India to its sports portfolio
BusinessUpdated 1 hr ago

Aurobindo Pharma’s Q2 FY27 net up 32% at ₹1124 cr

BusinessLine4 November 2026 at 8:45 pm IST
Image: BusinessLine

The total revenue of the Hyderabad-based company grew 24 per cent

Continue reading on BusinessLine

Hello Headlines links you to the original publisher for the full story.

Read full story

More in Business

See all

US Democratic win unlikely to ease firms' cost, tariff woes in near term, executives say

BusinessLine4 min ago

Centre earmarks ₹2,814 crore to boost lithium, nickel processing

The Hindu9 min ago

Beyond heavy trucks: How Tata eyes growth through Iveco’s engines

BusinessLine12 min ago

New entrants eat into SIP inflows of listed Mutual funds

BusinessLine16 min ago